ABSTRACT
BACKGROUND: Ficus palmata (Fig), are distributed in different parts of the world, and are used in traditional medicine to treat various ailments including inflammation, tumor, epilepsy, jaundice, influenza and bacillary dysentery. The present study aimed to evaluate the antidiarrheal, antisecretary, antispasmodic, antiulcer and anti motility properties of Ficus palmata. METHODS: In-vivo, in-vitro and in-silico techniques were used to investigate various gastrointestinal effects of Ficus palmata. Antidiarrheal, antisecretary, antispasmodic, antiulcer, anti motility and molecular docking were performed using castor oil induced diarrhea and fluid accumulation, isolated tissue preparations, ethanol-HCl induced ulcer assay, charcoal meal transit time and Auto Doc Vina. RESULTS: Ficus palmata crude extract (Fp.Cr) exhibited protection against castor oil-induced diarrhea in mice and dose-dependently inhibited intestinal fluid secretions. Fp.Cr caused relaxation of spontaneous and K+ (80 Mm)-induced contractions in isolated rabbit jejunum preparations. It showed protective effect against gastric ulcers induced by ethanol-hydrochloric acid in rats. Fp.Cr reduced distance travelled by charcoal meal in the gastrointestinal transit model in mice. The plant constituents: psoralenoside and bergapten showed high binding affinities (E-value ≥ - 6.5 Kcal/mol) against histaminergic H1, calmodulin and voltage gated L-type calcium channels, while showed moderate affinities (E-value ≥7 Kcal/mol) against dopaminergic D2, adrenergic α1, muscranic M3, mu-opioid, whereas revealed lower affinities (E-value ≥9.5 Kcal/mol) vs. muscranic M1, histaminergic H2 and H+/K+ ATPase pump. Germanicol acetate and psoralene exhibited weak affinities against aforementioned targets. CONCLUSION: This study reveals that Ficus palmata possesses anti-diarrheal, anti-secretory, anti-spasmodic, anti-motility and anti-ulcer activities. The various constituents reveal different binding affinities against target proteins, which mediate the gastrointestinal functions.
Subject(s)
Diarrhea , Ficus , Gastrointestinal Agents , Parasympatholytics , Plant Extracts , Animals , Castor Oil/adverse effects , Diarrhea/chemically induced , Diarrhea/metabolism , Female , Gastrointestinal Agents/chemistry , Gastrointestinal Agents/metabolism , Gastrointestinal Agents/pharmacology , Gastrointestinal Transit/drug effects , Jejunum/chemistry , Jejunum/metabolism , Male , Mice , Mice, Inbred BALB C , Molecular Docking Simulation , Parasympatholytics/chemistry , Parasympatholytics/metabolism , Parasympatholytics/pharmacology , Plant Extracts/chemistry , Plant Extracts/metabolism , Plant Extracts/pharmacology , Rabbits , Rats, Sprague-Dawley , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/metabolismSubject(s)
Gastrointestinal Agents/therapeutic use , Irritable Bowel Syndrome/drug therapy , Parasympatholytics/therapeutic use , Animals , Clinical Trials as Topic/methods , Gastrointestinal Agents/metabolism , Humans , Irritable Bowel Syndrome/diagnosis , Mentha piperita , Parasympatholytics/metabolism , Plant Oils/metabolism , Plant Oils/therapeutic use , Probiotics/metabolism , Probiotics/therapeutic useABSTRACT
Highly methoxylated flavones, which have known potential as cancer chemopreventive agents, accumulate on the leaf surfaces of some plant species and their physiological role is to protect the plant against harmful UV radiation. Xanthomicrol is one of the methoxylated flavones currently attracting most attention from researchers worldwide because of its promising pharmacological activities, including anti-spasmodic, anti-platelet and anti-cancer effects, among others. This review covers the chemistry and biological origin, distribution and pharmacological activity of xanthomicrol. Knowledge of the botanical distribution of this compound will not only encourage the use of plant sources for pharmacological purposes, but will also serve as a reference in the search for this valuable flavonoid in another genus or family. New approaches to xanthomicrol production are also described, including biotechnological attempts to develop xanthomicrol-producing plant cell factories.
Subject(s)
Fabaceae/chemistry , Flavones/chemistry , Flavonoids/chemistry , Lamiaceae/chemistry , Anti-Infective Agents/chemistry , Anti-Infective Agents/isolation & purification , Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Anticarcinogenic Agents/chemistry , Anticarcinogenic Agents/isolation & purification , Anticarcinogenic Agents/metabolism , Anticarcinogenic Agents/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Flavones/biosynthesis , Flavones/isolation & purification , Flavones/pharmacology , Flavonoids/biosynthesis , Flavonoids/isolation & purification , Flavonoids/pharmacology , Humans , Parasympatholytics/chemistry , Parasympatholytics/isolation & purification , Parasympatholytics/metabolism , Parasympatholytics/pharmacology , Plant Extracts/chemistry , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/isolation & purification , Platelet Aggregation Inhibitors/metabolism , Platelet Aggregation Inhibitors/pharmacologyABSTRACT
The diterpenes ent-kaur-16-en-19-oic acid (1) and ent-beyer-15-en-19-oic acid (2) are the major constituents of a spasmolytic diterpenic mixture obtained from the roots of Viguiera hypargyrea, a Mexican medicinal plant. Microbial transformation of 1 and 2 was performed with Aspergillus niger. Two metabolites, ent-7alpha,11beta-dihydroxy-kaur-16-en-19-oic acid (4) and ent-1beta,7alpha-dihydroxy-kaur-16-en-19-oic acid (5), were isolated from the incubation of 1, and one metabolite, ent-1beta,7alpha-dihydroxy-beyer-15-en-19-oic acid (6), was isolated in high yield (40%) from 2. The structures were elucidated on the basis of spectroscopic analyses and confirmed by X-ray crystallographic studies. Compounds 1-4 and 6 and methyl ester derivatives 4a and 6a were evaluated for their ability to inhibit the electrically induced contraction of guinea-pig ileum. Compounds 1, 3, 4, 4a and 5 were significantly active. These results showed that dihydroxylation of 1 at 7beta, 11alpha-, and 1alpha, 7beta-positions resulted in a loss of potency.
Subject(s)
Aspergillus niger/metabolism , Asteraceae/chemistry , Diterpenes/metabolism , Parasympatholytics/pharmacology , Plant Extracts/metabolism , Animals , Biotransformation , Crystallography, X-Ray , Guinea Pigs , Hydroxylation , Ileum/drug effects , In Vitro Techniques , Molecular Structure , Muscle, Smooth/drug effects , Parasympatholytics/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant RootsABSTRACT
Here we studied muscarinic receptors in the gerbil thalamus at 8 different ages - from 6 to 36 months - using receptor and functional autoradiography. The pharmacological profile inhibiting [(3)H]N-methyl scopolamine ([(3)H]NMS) binding with 50 and 200 nM pirenzepine, 30 nM pFHHSiD and 100 nM AF-DX 116 revealed the predominance of the M(2) muscarinic subtype in the thalamic nuclei studied, mainly in the anteroventral, anteromedial and paraventricular thalamic nuclei. These data correlated with the highest [(35)S]guanylyl-5'-O-(gamma-thio)-triphosphate ([(35)S]GTP gamma S) binding induced in these nuclei by the muscarinic agonist oxotremorine in functional autoradiographic assays. Significant aging-dependent increases in the functional response in these three nuclei were observed, but only the anteroventral and anteromedial thalamic nuclei showed aging-dependent increases in [(3)H]NMS binding. Since these nuclei exert relevant functions, in which cholinergic pathways are involved and acetylcholine release is reported to decrease during aging, we suggest that the anteroventral and anteromedial thalamic nuclei would play critical roles in the cholinergic transmission that require compensatory mechanisms during the aging process and that are not observed in other thalamic nuclei.
Subject(s)
Acetylcholine/metabolism , Aging/metabolism , Binding, Competitive/physiology , Receptors, Muscarinic/metabolism , Synaptic Transmission/physiology , Thalamus/metabolism , Animals , Anterior Thalamic Nuclei/drug effects , Anterior Thalamic Nuclei/metabolism , Binding, Competitive/drug effects , Gerbillinae , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Male , Muscarinic Antagonists/metabolism , Neural Pathways/drug effects , Neural Pathways/metabolism , Parasympatholytics/metabolism , Receptor, Muscarinic M2/drug effects , Receptor, Muscarinic M2/metabolism , Receptors, Muscarinic/drug effects , Synaptic Transmission/drug effects , Thalamus/drug effectsABSTRACT
Evaluation of rectal and rectosigmoid sensation is important in basic, clinical and pharmacological studies. New methods to evoke and assess multimodal (electrical, thermal and mechanical) experimental pain of the upper gut activate distinct pathways and mimics clinical pain. The aims of the current study were to characterize the sensory response and reproducibility to multimodal stimulation of rectum and the rectosigmoid. A multimodal rectal probe was developed. Mucosal electrostimulation was delivered at the recto-sigmoid junction. In Rectum, impedance planimetry was used for measurement of cross-sectional area (CSA) during distension. Circulation of water within the bag at either 4 or 60 degrees C was applied for thermal stimulation. The method was tested in 12 healthy volunteers (six men mean age 32 years) on two subsequent days. Mechanical and sensory responses and referred pain areas were assessed. Stimulation with electrical, thermal and mechanical modalities resulted in different sensory perceptions. The relationship between stimulus intensity and sensory response was linear for all modalities. Sensory response to different modalities did not differ between investigation days (all P-values > 0.1). Approximately 75% of subjects felt referred pain in distinct skin locations. Between-days reproducibility was good for all modalities [intra-class correlation (ICC) > or = 0.6]. At sensory threshold, CSA showed best reproducibility (ICC > or = 0.9). At pain detection threshold stretch ratio, CSA and electrostimulation showed best reproducibility (ICC = 1.0; 0.9; 0.9). The present model was easily implemented, robust and showed good reproducibility. It can be used to study pathophysiology or pharmacological interventions in healthy controls and in patients with diseases involving the distal hindgut.
Subject(s)
Abdominal Pain/physiopathology , Colon, Sigmoid/physiology , Pain Measurement/methods , Rectum/physiology , Abdominal Pain/etiology , Adult , Butylscopolammonium Bromide/metabolism , Electric Stimulation , Humans , Male , Pain Threshold , Pain, Referred/physiopathology , Parasympatholytics/metabolism , Reproducibility of Results , Stress, Mechanical , TemperatureABSTRACT
Glycyrrhizae radix is used to treat abdominal pain as a component of shakuyakukanzoto (shaoyao-gancao-tang), a traditional Chinese medicine formulation. Previously, we have reported the isolation of glycycoumarin as a potent antispasmodic with an IC50 value of 2.93+/-0.94 microM for carbamylcholine (CCh)-induced contraction of mouse jejunum from an aqueous extract of Glycyrrhizae radix (licorice), and clarified that its mechanism of action involves inhibition of phosphodiesterase 3. The purpose of the present study was to examine an antispasmodic principle of licorice other than glycycoumarin. Isoliquiritigenin was isolated from an aqueous extract of licorice as a potent relaxant, which inhibited the contraction induced by various types of stimulants, such as CCh, KCl, and BaCl2 with IC50 values of 4.96+/-1.97 microM, 4.03+/-1.34 microM and 3.70+/-0.58 microM, respectively, which are close to those of papaverine. However, the amount of isoliquiritigenin in the aqueous extract of licorice was very small. When the aqueous licorice extract was treated with naringinase, the amounts of glycosides such as isoliquiritin, which were abundant but had much less potent relaxant activity, were decreased while isoliquiritigenin was increased. At the time, the relaxant activity of the treated sample was increased significantly, shifting the IC50 from 358+/-104 to 150+/-38 microg/ml for CCh-induced contraction. Isoliquiritigenin also showed the most potent inhibition of mouse rectal contraction induced by CCh with an IC50 value of 1.70+/-0.07 microM. These results suggest that isoliquiritigenin acts as a potent relaxant in the lower part of the intestine by transformation from its glycosides.
Subject(s)
Chalcones/pharmacology , Glycyrrhiza uralensis/chemistry , Intestines/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Parasympatholytics/pharmacology , Animals , Chalcones/isolation & purification , Chalcones/metabolism , Dose-Response Relationship, Drug , Glycoside Hydrolases/metabolism , Ileum/drug effects , In Vitro Techniques , Jejunum/drug effects , Male , Mice , Mice, Inbred ICR , Multienzyme Complexes/metabolism , Papaverine/pharmacology , Parasympatholytics/isolation & purification , Parasympatholytics/metabolism , Phosphodiesterase Inhibitors/pharmacology , Plant Extracts/pharmacology , Plant Roots , Rectum/drug effects , beta-Glucosidase/metabolismABSTRACT
The aim of this study was to examine the influence of different fat diets on muscarinic acetylcholine receptor binding. Nineteen male Sprague-Dawley rats were divided into four groups and fed a diet of either high saturated fat, n-6 polyunsaturated fatty acid (PUFA), n-3 PUFA or low fat (control) for 8 weeks. Using quantitative autoradiography, [(3)H]pirenzepine binding to muscarinic M1/M4 receptors and [(3)H]AF-DX384 binding to M2/M4 receptors were measured throughout the brain in all four groups. The main findings were that compared to the low fat control group, M2/M4 receptor binding was significantly reduced in the dorsolateral, dorsomedial and ventromedial parts of the caudate putamen (61-64%, p < 0.05), anterior cingulate cortex (59%, p < 0.01), dentate gyrus and CA1-3 fields of the hippocampus (32-43%, p < 0.01) of rats on a high n-6 PUFA diet; however, no differences in M1/M4 receptor binding densities between the four groups were observed. These results suggest that a diet high in n-6 PUFA, but not of n-3 PUFAs or saturated fat, may selectively alter M2/M4 receptor-mediated signal transduction in the rat brain.
Subject(s)
Binding, Competitive/physiology , Brain/metabolism , Fatty Acids, Omega-6/pharmacology , Food, Formulated , Food, Fortified , Receptor, Muscarinic M2/metabolism , Acetylcholine/metabolism , Animals , Arachidonic Acid/metabolism , Binding, Competitive/drug effects , Brain/drug effects , Brain Mapping , Down-Regulation/drug effects , Down-Regulation/physiology , Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-6/metabolism , Male , Muscarinic Antagonists/metabolism , Parasympatholytics/metabolism , Pirenzepine/metabolism , Radioligand Assay , Rats , Rats, Sprague-Dawley , Receptor, Muscarinic M2/drug effects , Receptor, Muscarinic M4/drug effects , Receptor, Muscarinic M4/metabolism , Signal Transduction/drug effects , Synaptic Transmission/physiologyABSTRACT
Although a potential target site of general anesthetics is primarily the GABA A receptor, a chloride ion channel, a previous study suggested that the intravenous general anesthetic propofol attenuates the M1 muscarinic acetylcholine receptor (M1 receptor)-mediated signal transduction. In the present study, we examined the target site of propofol in M1 receptor-mediated signal transduction. Two-electrode voltage-clamp method was used in Xenopus oocytes expressing both M1 receptors and associated G protein alpha subunits (Gqalpha). Propofol inhibited M1 receptor-mediated signal transduction in a dose-dependent manner (IC50 = 50 nM). Injection of guanosine 5'-3-O-(thio)triphosphate (GTPgammaS) into oocytes overexpressing Gqalpha was used to investigate direct effects of propofol on G protein coupled with the M1 receptor. Propofol did not affect activation of Gqalpha-mediated signal transduction with the intracellular injection of GTPgammaS. We also studied effects of propofol on l-[N-methyl-3H]scopolamine methyl chloride ([3H]NMS) binding and M1 receptor-mediated signal transduction in mammalian cells expressing M1 receptor. Propofol inhibited the M1 receptor-mediated signal transduction but did not inhibit binding of [3H]NMS. Effects of propofol on Gs- and Gi/o-coupled signal transduction were investigated, using oocytes expressing the beta2 adrenoceptor (beta2 receptor)/cystic fibrosis transmembrane conductance regulator or oocytes expressing the M2 muscarinic acetylcholine receptor (M2 receptor)/Kir3.1 (a member of G protein-gated inwardly rectifying K(+) channels). Neither beta2 receptor-mediated nor M2 receptor-mediated signal transduction was inhibited by a relatively high concentration of propofol (50 microM). These results indicate that propofol inhibits M1 receptor-mediated signal transduction by selectively disrupting interaction between the receptor and associated G protein.
Subject(s)
Anesthetics, Intravenous/pharmacology , Potassium Channels, Inwardly Rectifying , Propofol/pharmacology , Receptor, Muscarinic M1/drug effects , Acetylcholine/metabolism , Animals , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Electrophysiology , G Protein-Coupled Inwardly-Rectifying Potassium Channels , GTP-Binding Protein alpha Subunits, Gi-Go/physiology , GTP-Binding Protein alpha Subunits, Gs/physiology , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Humans , N-Methylscopolamine/metabolism , Oocytes/metabolism , Parasympatholytics/metabolism , Patch-Clamp Techniques , Potassium Channels/drug effects , Potassium Channels/metabolism , Radioligand Assay , Rats , Receptor, Muscarinic M1/metabolism , Receptor, Muscarinic M2/drug effects , Receptor, Muscarinic M2/metabolism , Signal Transduction/drug effects , Xenopus laevisABSTRACT
The flavonoid quercetin is an antioxidant which occurs in foods mainly as glycosides. The sugar moiety in quercetin glycosides affects their bioavailability in humans. Quercetin-3-rutinoside is an important form of quercetin in foods, but its bioavailability in humans is only 20% of that of quercetin-4'-glucoside. Quercetin-3-rutinoside can be transformed into quercetin-3-glucoside by splitting off a rhamnose molecule. We studied whether this 3-glucoside has the same high bioavailability as the quercetin-4'-glucoside. To that end we fed five healthy men and four healthy women (19-57 y) a single dose of 325 micromol of pure quercetin-3-glucoside and a single dose of 331 micromol of pure quercetin-4'-glucoside and followed the plasma quercetin concentrations. The bioavailability was the same for both quercetin glucosides. The mean peak plasma concentration of quercetin was 5.0+/-1.0 micromol/L (+/-SE) after subjects had ingested quercetin-3-glucoside and 4.5+/-0.7 micromol/L after quercetin-4'-glucoside consumption. Peak concentration was reached 37 +/-12 min after ingestion of quercetin-3-glucoside and 27+/-5 min after quercetin-4'-glucoside. Half-life of elimination of quercetin from blood was 18.5+/-0.8 h after ingestion of quercetin-3-glucoside and 17.7+/-0.9 h after quercetin-4'-glucoside. We conclude that quercetin glucosides are rapidly absorbed in humans, irrespective of the position of the glucose moiety. Conversion of quercetin glycosides into glucosides is a promising strategy to enhance bioavailability of quercetin from foods.
Subject(s)
Parasympatholytics/pharmacokinetics , Quercetin/analogs & derivatives , Administration, Oral , Adult , Area Under Curve , Chromatography, High Pressure Liquid , Female , Half-Life , Humans , Male , Middle Aged , Parasympatholytics/chemistry , Parasympatholytics/metabolism , Plant Extracts/chemistry , Plant Extracts/metabolism , Plant Extracts/pharmacokinetics , Quercetin/chemistry , Quercetin/metabolism , Quercetin/pharmacokinetics , Structure-Activity RelationshipABSTRACT
The effect of protein-energy malnutrition on the muscarinic receptor density as indicated by 3H-N-methylscopolamine binding, and acetylcholinesterase activity was studied in several brain areas (hippocampus, motor area, somatosensory area, and basal ganglia) of adult female rats. Malnutrition tended to cause a decrease in muscarinic receptors in the motor cortex (undernourished 350.0 +/- 33.5 vs. control 410.0 +/- 26.9 fmol/mg protein) and somatosensory cortex (undernourished 357.1 +/- 35.9 vs. control 416.7 +/- 29.4 fmol/mg protein). However, significant decreases in muscarinic receptor occurred in the hippocampus (undernourished 319.2 +/- 31.7 vs. control 403.1 +/- 43.6 fmol/mg protein) and basal ganglia (undernourished 297.0 +/- 11.8 vs. control 401.3 +/- 17.7 fmol/mg protein). No significant differences in acetylcholinesterase activity or protein content were observed between control and undernourished animals in any of the brain areas studied.
Subject(s)
Acetylcholinesterase/metabolism , Brain Chemistry/physiology , Brain/enzymology , Protein-Energy Malnutrition/physiopathology , Receptors, Muscarinic/metabolism , Animals , Basal Ganglia/chemistry , Basal Ganglia/metabolism , Binding, Competitive , Body Weight , Female , Hippocampus/chemistry , Hippocampus/metabolism , Motor Cortex/chemistry , Motor Cortex/metabolism , N-Methylscopolamine , Parasympatholytics/metabolism , Proteins/analysis , Proteins/metabolism , Rats , Rats, Wistar , Scopolamine Derivatives/metabolism , Somatosensory Cortex/chemistry , Somatosensory Cortex/metabolism , Tritium/metabolismABSTRACT
The traditional herbal remedy from Psidium guajava leaves has been medically proposed in Mexico as effective treatment of acute diarrhea. A methanolic leaf extract was subjected to a bioassay-guided isolation of spasmolytic constituents. Six fractions were separated on a polyvinylpolypyrrolidine (PVPP) column using a water methanol-gradient. The fraction containing flavonols inhibited peristalsis of guinea pig ileum in vitro. A trace of quercetin aglycone together with five glycosides was isolated from this active fraction and identified as quercetin 3-O-alpha-L-arabinoside (guajavarin); quercetin 3-O-beta-D-glucoside (isoquercetin); quercetin 3-O-beta-D-galactoside (hyperin); quercetin 3-O-beta-L-rhamnoside (quercitrin) and quercetin 3-O-gentobioside. Biological activity of each pure compound was studied in the same bioassay. Obtained results suggest that the spasmolytic activity of the Psidium guajava leaf remedy is mainly due to the aglycone quercetin, present in the leaf and in the extract mainly in the form of five flavonols, and whose effect is produced when these products are hydrolyzed by gastrointestinal fluid.
Subject(s)
Antidiarrheals , Glycosides , Ileum/drug effects , Parasympatholytics/pharmacology , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Quercetin/analogs & derivatives , Quercetin/pharmacology , Animals , Drug Evaluation, Preclinical , Gastric Acid/metabolism , Guinea Pigs , Hydrolysis , Male , Methanol , Mexico , Muscle Relaxation/drug effects , Muscle, Smooth/drug effects , Parasympatholytics/isolation & purification , Parasympatholytics/metabolism , Plant Extracts/isolation & purification , Plant Extracts/metabolism , Quercetin/isolation & purification , Quercetin/metabolismABSTRACT
The cholinergic system in the central nervous system is an important component of the neural circuitry of learning, memory and cognition. A decline of cholinergic innervation in the human brain is a characteristic feature of dementia of Alzheimer's type. In this study, changes in cholinergic markers were studied after a unilateral lesion of the nucleus basalis magnocellularis (nbM). Acetylcholinesterase (AChE) histochemistry showed a loss of cortical AChE-containing neurons, and choline acetyltransferase (ChAT) immunohistochemistry demonstrated a loss of cholinergic cells in nbM. The localizations of muscarinic M1 and M2 receptors using [3H]pirenzepine ([3H]PZ) and [3H]AF-DX 384, respectively, were studied by quantitative autoradiography 1, 2, 4 and 6 weeks following unilateral ibotenic acid lesion of nbM. A significant decrease in [3H]PZ binding sites was observed at postlesion week 1 in the parietal and temporal cortices. The decrease in [3H]AF-DX 384 binding sites on the lesioned side was observed throughout frontal, parietal and temporal cortices after postlesion week 1, with a significant increase after 6 weeks, possibly as result of loss of presynaptic receptors and upregulation of postsynaptic ones. Moreover, laminar distribution after nbM lesion shows that M1 and M2 receptor binding sites are more affected in superficial layers (I,II,III) than in the deep layers (IV,V,VI), depending on ligand, postlesion period and cortical region. Furthermore, nbM lesion causes a higher deficit of M2 receptors than of M1 receptors. These data suggest the existence of a presynaptic population as well as a postsynaptic population of M1 and M2 receptors which are differently affected after unilateral nbM lesion.
Subject(s)
Cerebral Cortex/metabolism , Neurons/metabolism , Olivary Nucleus/physiology , Receptors, Muscarinic/metabolism , Acetylcholinesterase/metabolism , Analysis of Variance , Animals , Autoradiography , Choline O-Acetyltransferase/metabolism , Frontal Lobe/metabolism , Ibotenic Acid , Immunohistochemistry , Male , Parasympatholytics/metabolism , Parietal Lobe/metabolism , Pirenzepine/analogs & derivatives , Pirenzepine/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Muscarinic/classification , Temporal Lobe/metabolism , TritiumABSTRACT
Cells of the murine neuroblastoma clone N1E-115 possess muscarinic receptors that influence the intracellular level of cyclic nucleotides. The stimulation of [3H]cyclic GMP levels occurs only with intact cells and has an EC50 near the "low-affinity" agonist equilibrium dissociation constant (KL) determined by radioligand binding assays. The inhibition of prostaglandin E1-stimulated [3H]cyclic AMP formation has an EC50 close to the value for the "high-affinity" agonist equilibrium dissociation constant (KH). During sequential subculturing in medium supplemented with newborn bovine serum, the inhibition of [3H]cyclic AMP was maintained, but the [3H]cyclic GMP response declined dramatically, and after 7 subculturings it was essentially absent. The time course for [3H]cyclic GMP formation in a late subculture with an 88% loss of the response was identical with the time course in early subcultures. A normal [3H]cyclic GMP response to bradykinin and histamine was demonstrated to be present in cells that had lost the [3H]cyclic GMP response to carbachol. The EC50 and KD values for the two muscarinic responses and binding sites increased 3- to 4-fold after several subculturings. A 90% loss of low-affinity binding sites was closely correlated with a similar loss of the [3H]cyclic GMP response. High-affinity binding sites did not decline significantly in concentration until the 11th subculture, where the total number of muscarinic sites was only 6% of the earliest subculture. In all subcultures, however, the ability of the muscarinic receptor to decrease [3H]cyclic AMP levels was maintained. These data, which show that the subculturing of N1E-115 cells in medium supplemented with newborn calf serum results in a selective loss of one muscarinic function, strongly support the hypothesis that these cells contain two separate muscarinic receptor-effector systems. One receptor subtype or conformation has a low affinity for the agonist and mediates cyclic GMP formation. The other receptor subtype or conformation has a higher affinity for the agonist and mediates an inhibition of prostaglandin E1-stimulated cyclic AMP formation.